Buy Proteostasis Therapeutics Stock | PTI Stock Price & Latest News | Public
PTI

Proteostasis Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About PTI

    Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.13
    -0.19
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.14

    Actual EPS
    Q4 2020

    Stats

    Market Cap$56,88M
    Volume1,06k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.72
    1 Year Low$0.87
    Open$1.07
    High$1.07
    Low$1.04

    Buy any stock with any amount of money.

    Download the App
    Download the app